AMY ANDERSON: Open Payments
NPI 1396362299 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,770 in 65 payments from 13 companies in 2025. Trend: 2023 $693 · 2024 $1,175 · 2025 $1,770
Food & beverage: $1,770
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $599 |
| Aimmune Therapeutics, Inc. | 11 | $324 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $184 |
| Janssen Biotech, Inc. | 5 | $173 |
| Boston Scientific Corporation | 1 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $86 |
| PFIZER INC. | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $40 |
| Ardelyx, Inc. | 2 | $36 |
Products named: SKYRIZI, ZENPEP, RINVOQ, TREMFYA, Lumenis Pulse 120H, ENTYVIO, DUPIXENT, XIFAXAN.
Industry payments across MT — which companies pay providers there.
